Anavex
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Anavex and other ETFs, options, and stocks.About AVXL
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome.
AVXL Key Statistics
Stock Snapshot
As of today, Anavex(AVXL) shares are valued at $2.63. The company's market cap stands at 243.33M, with a P/E ratio of -18.14.
On 2026-09-10, Anavex(AVXL) stock moved within a range of $2.63 to $2.74. With shares now at $2.63, the stock is trading 0.0% above its intraday low and -4.0% below the session's peak.
Trading activity shows a volume of 132.07K, compared to an average daily volume of 690.17K.
The stock's 52-week range extends from a low of $2.26 to a high of $10.38.
The stock's 52-week range extends from a low of $2.26 to a high of $10.38.
AVXL News
Anavex Life Sciences ( (AVXL) ) has shared an update. On September 9, 2026, Anavex Life Sciences reported progress in its clinical program for ANAVEX 2‑73 in R...
The firm said,” PVG Asset Management, a stockholder of Anavex (AVXL) Life Sciences, believes the Anavex Board of Directors should be replaced and an experienced...
PVG Asset Management Corp., a stockholder of Anavex (AVXL) Life Sciences Corp., sent an open letter to the stockholders of Anavex. In its letter, PVG details wh...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.